The proposed registry would focus on the most common treatments, such as musculoskeletal health solutions.
To participate in the registry, clinics would have to gain patients’informed consent to share treatment and follow-up data for research purposes. The data could be linked to administrative databases to provide follow-up on safety and effectiveness.
Dr. Rossi is a medical genetics professor and the scientific director of BC Regenerative Medicine Network at the University of British Columbia in Vancouver, Canada. Dr. Illes is a neurology professor and the Canada Research Chair in Neuroethics at UBC.
More articles on biologics:
3D technology helps identify stem cells in muscle: 3 things to know
Male patients with ankylosing spondylitis respond better to biologics, study finds
Stem cells ‘will change medicine forever’ says former surgeon & stem cell expert
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
